Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment

SIMPLE SUMMARY: β-thalassemia syndromes are clinically and genetically heterogeneous blood disorders presented by β-chain deficiency in hemoglobin production. Despite improvements in transfusion practices and chelation treatment, many lingering challenges have encouraged researchers to develop newer...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahimmanesh, Ilnaz, Boshtam, Maryam, Kouhpayeh, Shirin, Khanahmad, Hossein, Dabiri, Arezou, Ahangarzadeh, Shahrzad, Esmaeili, Yasaman, Bidram, Elham, Vaseghi, Golnaz, Haghjooy Javanmard, Shaghayegh, Shariati, Laleh, Zarrabi, Ali, Varma, Rajender S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219845/
https://www.ncbi.nlm.nih.gov/pubmed/35741383
http://dx.doi.org/10.3390/biology11060862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219845/
https://www.ncbi.nlm.nih.gov/pubmed/35741383
http://dx.doi.org/10.3390/biology11060862

Ejemplares similares